Related Experiment Video

Updated: May 12, 2026

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice
10:31

Comparative Proteomic Analysis of Whole Kidney, Medulla, and Cortical Tubules in Diabetic Pathogenesis of Kidney Injury in Mice

Published on: May 2, 2025

Proteomics in acute kidney injury--current status and future promise

Julie Ho1, Allison Dart, Claudio Rigatto

  • 1Section of Nephrology, Department Internal Medicine, University of Manitoba, Winnipeg, MB, Canada, jho@exchange.hsc.mb.ca.

Pediatric Nephrology (Berlin, Germany)
|April 19, 2013
PubMed

Insights

Developing novel biomarkers for pediatric acute kidney injury (AKI) is crucial for early diagnosis. This review highlights "-omic" technologies and challenges in identifying non-invasive biomarkers to improve patient outcomes.

Area of Science:

  • Biomarker discovery
  • Pediatric nephrology
  • Translational research

Background:

  • Pediatric acute kidney injury (AKI) presents significant morbidity, mortality, and healthcare costs.
  • Current therapeutic interventions for AKI are limited, partly due to late diagnosis.
  • Early identification of renal injury is critical for effective therapeutic intervention.

Purpose of the Study:

  • To review non-invasive pediatric AKI biomarkers.
  • To focus on biomarkers identified through unbiased omic technologies.
  • To highlight methodological and implementation challenges in biomarker discovery.

Main Methods:

  • Review of transcriptomic, proteomic, and metabolomic technologies for AKI biomarker identification.
  • Analysis of existing literature on non-invasive pediatric AKI biomarkers.
  • Discussion of emerging proteomic techniques for biomarker discovery.

Main Results:

  • Omic technologies offer unbiased approaches to identify novel AKI biomarkers.
  • Various biomarkers have been identified using transcriptomic, proteomic, and metabolomic methods.
  • Methodological and implementation challenges exist in translating these biomarkers into clinical practice.

Conclusions:

  • Development of novel non-invasive biomarkers is essential for early AKI diagnosis in children.
  • Overcoming implementation challenges is key to utilizing biomarkers for timely therapeutic intervention.
  • Advancements in proteomic techniques hold promise for future AKI biomarker discovery and improved patient outcomes.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...